Literature DB >> 10921977

Fluorescence-based quantitative methods for detecting human immunodeficiency virus type 1-induced syncytia.

S Wünschmann1, J T Stapleton.   

Abstract

Cell fusion induced by human immunodeficiency virus type 1 (HIV-1) is usually assessed by counting multinucleated giant cells (syncytia) visualized by light microscopy. Currently used methods do not allow quantification of syncytia, nor do they estimate the number of cells involved in cell fusion. We describe two fluorescence-based methods for the detection and quantification of HIV-1-induced in vitro syncytium formation. The lymphoblastoid cell lines MT-2 and SupT1 were infected with syncytium-inducing (SI) HIV-1 isolates. Syncytia were detected by DNA staining with propidium iodide using flow cytometry to determine cell size or by two-color cytoplasmic staining of infected cell populations by using fluorescence microscopy. Both methods were able to detect and quantify HIV-induced syncytia. The methods could distinguish between SI and non-SI HIV isolates and could be used with at least two separate types of CD4(+) T-cell lines. Small syncytia can be readily identified by the two-color cytoplasmic staining method. Both methods were also shown to be useful for evaluating antiretroviral compounds, as demonstrated by the accurate assessment of HIV inhibition by azidothymidine (zidovudine), dideoxycytidine (zalcytibine), and hydroxyurea. These fluorescence-based assays allow a rapid and practical method for measuring HIV replication and anti-HIV activity of potential inhibitory compounds.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10921977      PMCID: PMC87184     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.

Authors:  A Björndal; H Deng; M Jansson; J R Fiore; C Colognesi; A Karlsson; J Albert; G Scarlatti; D R Littman; E M Fenyö
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  A new classification for HIV-1.

Authors:  E A Berger; R W Doms; E M Fenyö; B T Korber; D R Littman; J P Moore; Q J Sattentau; H Schuitemaker; J Sodroski; R A Weiss
Journal:  Nature       Date:  1998-01-15       Impact factor: 49.962

3.  Detection and delineation of CXCR-4 (fusin) as an entry and fusion cofactor for T-tropic [correction of T cell-tropic] HIV-1 by three different monoclonal antibodies.

Authors:  T Hori; H Sakaida; A Sato; T Nakajima; H Shida; O Yoshie; T Uchiyama
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

4.  HIV-induced T cell syncytia are self-perpetuating and the primary cause of T cell death in culture.

Authors:  A Sylwester; S Murphy; D Shutt; D R Soll
Journal:  J Immunol       Date:  1997-04-15       Impact factor: 5.422

5.  Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection.

Authors:  A B van 't Wout; H Blaak; L J Ran; M Brouwer; C Kuiken; H Schuitemaker
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

Review 6.  Sulfated polysaccharides extracted from sea algae as potential antiviral drugs.

Authors:  M Witvrouw; E De Clercq
Journal:  Gen Pharmacol       Date:  1997-10

7.  Inhibition of HIV type 1 infectivity by constrained alpha-helical peptides: implications for the viral fusion mechanism.

Authors:  J K Judice; J Y Tom; W Huang; T Wrin; J Vennari; C J Petropoulos; R S McDowell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

8.  Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro.

Authors:  K Saha; G Bentsman; L Chess; D J Volsky
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

Review 9.  Host factors and the pathogenesis of HIV-induced disease.

Authors:  A S Fauci
Journal:  Nature       Date:  1996-12-12       Impact factor: 49.962

10.  Modulation of human immunodeficiency virus type 1-induced syncytium formation by the conformational state of LFA-1 determined by a new luciferase-based syncytium quantitative assay.

Authors:  B Barbeau; J F Fortin; N Genois; M J Tremblay
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

View more
  8 in total

1.  Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor.

Authors:  S Wünschmann; J D Medh; D Klinzmann; W N Schmidt; J T Stapleton
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle.

Authors:  Levon G Abrahamyan; Samvel R Mkrtchyan; James Binley; Min Lu; Grigory B Melikyan; Fredric S Cohen
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Full-length GB virus C (Hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells.

Authors:  J Xiang; S Wünschmann; W Schmidt; J Shao; J T Stapleton
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  Chun Lu; Yi Zeng; Zan Huang; Li Huang; Chao Qian; Guixia Tang; Di Qin
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

5.  GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates.

Authors:  Emma L Mohr; Jinhua Xiang; James H McLinden; Thomas M Kaufman; Qing Chang; David C Montefiori; Donna Klinzman; Jack T Stapleton
Journal:  J Immunol       Date:  2010-09-08       Impact factor: 5.422

Review 6.  Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring.

Authors:  Mark A Lifson; Mehmet Ozgun Ozen; Fatih Inci; ShuQi Wang; Hakan Inan; Murat Baday; Timothy J Henrich; Utkan Demirci
Journal:  Adv Drug Deliv Rev       Date:  2016-06-02       Impact factor: 15.470

7.  Characterization of a peptide domain within the GB virus C NS5A phosphoprotein that inhibits HIV replication.

Authors:  Jinhua Xiang; James H McLinden; Qing Chang; Emma L Jordan; Jack T Stapleton
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

8.  Wear particles derived from metal hip implants induce the generation of multinucleated giant cells in a 3-dimensional peripheral tissue-equivalent model.

Authors:  Debargh K Dutta; Pushya A Potnis; Kelly Rhodes; Steven C Wood
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.